Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors

The use of protease inhibitors in human immunodeficiency virus type 1 (HIV-1) treatment is limited by adverse effects, including metabolic complications. To address these challenges, efforts are underway in the pursuit of more potent and less toxic HIV-1 protease inhibitors. Repurposing existing dru...

Full description

Bibliographic Details
Main Authors: Sunday N. Okafor, Abigail Meyer, Jay Gadsden, Fadi Ahmed, Lilian Guzmán, Hashim Ahmed, José A. Fernández Romero, Pavimol Angsantikul
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Molecules
Subjects:
HIV-1 protease
drug repurposing
drug discovery
HIV-1 protease inhibitors
Online Access:https://www.mdpi.com/1420-3049/28/17/6330

Internet

https://www.mdpi.com/1420-3049/28/17/6330

Similar Items